ASX - By Stock
|
NEU |
Re:
Share Price
|
|
good1234
|
13K |
6.1M |
10 |
06/09/24 |
06/09/24 |
ASX - By Stock
|
13K
|
6.1M
|
10
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Change of Director's Interest Notice x 1
|
|
good1234
|
12 |
4.5K |
3 |
06/09/24 |
06/09/24 |
ASX - By Stock
|
12
|
4.5K
|
3
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Change of Director's Interest Notice x 1
|
|
good1234
|
12 |
4.5K |
0 |
06/09/24 |
06/09/24 |
ASX - By Stock
|
12
|
4.5K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
good1234
|
13K |
6.1M |
0 |
03/09/24 |
03/09/24 |
ASX - By Stock
|
13K
|
6.1M
|
0
|
|
Charts
|
NEU |
Re:
NEU chart
|
|
good1234
|
2.0K |
1.0M |
4 |
02/09/24 |
02/09/24 |
Charts
|
2.0K
|
1.0M
|
4
|
|
Charts
|
NEU |
Re:
NEU chart
|
|
good1234
|
2.0K |
1.0M |
1 |
02/09/24 |
02/09/24 |
Charts
|
2.0K
|
1.0M
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
good1234
|
13K |
6.1M |
6 |
02/09/24 |
02/09/24 |
ASX - By Stock
|
13K
|
6.1M
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
good1234
|
13K |
6.1M |
5 |
02/09/24 |
02/09/24 |
ASX - By Stock
|
13K
|
6.1M
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
good1234
|
13K |
6.1M |
0 |
02/09/24 |
02/09/24 |
ASX - By Stock
|
13K
|
6.1M
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
good1234
|
13K |
6.1M |
4 |
02/09/24 |
02/09/24 |
ASX - By Stock
|
13K
|
6.1M
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
good1234
|
13K |
6.1M |
12 |
02/09/24 |
02/09/24 |
ASX - By Stock
|
13K
|
6.1M
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Rare paediatric disease priority review
|
|
good1234
|
32 |
23K |
2 |
02/09/24 |
02/09/24 |
ASX - By Stock
|
32
|
23K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
good1234
|
13K |
6.1M |
38 |
02/09/24 |
02/09/24 |
ASX - By Stock
|
13K
|
6.1M
|
38
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
good1234
|
13K |
6.1M |
3 |
01/09/24 |
01/09/24 |
ASX - By Stock
|
13K
|
6.1M
|
3
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Q3 2024 Investor Webinar Presentation
|
|
good1234
|
17 |
7.7K |
6 |
31/08/24 |
31/08/24 |
ASX - By Stock
|
17
|
7.7K
|
6
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Q3 Investor Webinar 30 August 2024
|
|
good1234
|
14 |
8.2K |
5 |
23/08/24 |
23/08/24 |
ASX - By Stock
|
14
|
8.2K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
The Whens and Whys of Top Biotech M&A Deals
|
|
good1234
|
123 |
55K |
1 |
23/08/24 |
23/08/24 |
ASX - By Stock
|
123
|
55K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
The Whens and Whys of Top Biotech M&A Deals
|
|
good1234
|
123 |
55K |
5 |
23/08/24 |
23/08/24 |
ASX - By Stock
|
123
|
55K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
good1234
|
2.5K |
857K |
2 |
23/08/24 |
23/08/24 |
ASX - By Stock
|
2.5K
|
857K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
good1234
|
13K |
6.1M |
14 |
23/08/24 |
23/08/24 |
ASX - By Stock
|
13K
|
6.1M
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
good1234
|
13K |
6.1M |
6 |
20/08/24 |
20/08/24 |
ASX - By Stock
|
13K
|
6.1M
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
good1234
|
13K |
6.1M |
24 |
20/08/24 |
20/08/24 |
ASX - By Stock
|
13K
|
6.1M
|
24
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
good1234
|
13K |
6.1M |
0 |
20/08/24 |
20/08/24 |
ASX - By Stock
|
13K
|
6.1M
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
good1234
|
13K |
6.1M |
2 |
20/08/24 |
20/08/24 |
ASX - By Stock
|
13K
|
6.1M
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
good1234
|
13K |
6.1M |
9 |
20/08/24 |
20/08/24 |
ASX - By Stock
|
13K
|
6.1M
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
good1234
|
1.4K |
779K |
11 |
18/08/24 |
18/08/24 |
ASX - By Stock
|
1.4K
|
779K
|
11
|
|
ASX - By Stock
|
ADO |
Re:
Ann: First Commercial Evaluation of AnteoBind NXT
|
|
good1234
|
95 |
31K |
25 |
17/08/24 |
17/08/24 |
ASX - By Stock
|
95
|
31K
|
25
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
good1234
|
2.5K |
857K |
0 |
17/08/24 |
17/08/24 |
ASX - By Stock
|
2.5K
|
857K
|
0
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
good1234
|
617 |
305K |
27 |
17/08/24 |
17/08/24 |
ASX - By Stock
|
617
|
305K
|
27
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
good1234
|
307 |
98K |
1 |
16/08/24 |
16/08/24 |
ASX - By Stock
|
307
|
98K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
good1234
|
307 |
98K |
3 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
307
|
98K
|
3
|
|
ASX - By Stock
|
ADO |
Re:
why ADO is a multi multi sagger
|
|
good1234
|
47 |
14K |
4 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
47
|
14K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
good1234
|
307 |
98K |
2 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
307
|
98K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
good1234
|
307 |
98K |
2 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
307
|
98K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
good1234
|
307 |
98K |
2 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
307
|
98K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
good1234
|
307 |
98K |
3 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
307
|
98K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
good1234
|
307 |
98K |
3 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
307
|
98K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
good1234
|
307 |
98K |
2 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
307
|
98K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
good1234
|
307 |
98K |
10 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
307
|
98K
|
10
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
good1234
|
307 |
98K |
1 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
307
|
98K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
good1234
|
307 |
98K |
2 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
307
|
98K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
good1234
|
307 |
98K |
1 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
307
|
98K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
good1234
|
307 |
98K |
0 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
307
|
98K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
good1234
|
307 |
98K |
3 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
307
|
98K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
good1234
|
307 |
98K |
2 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
307
|
98K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
good1234
|
307 |
98K |
3 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
307
|
98K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
good1234
|
307 |
98K |
2 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
307
|
98K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
good1234
|
307 |
98K |
5 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
307
|
98K
|
5
|
|
ASX - By Stock
|
ADO |
Re:
why ADO is a multi multi bagger
|
|
good1234
|
3.0K |
970K |
0 |
10/08/24 |
10/08/24 |
ASX - By Stock
|
3.0K
|
970K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
NEU has been completely de-risked at this point....
|
|
good1234
|
13 |
6.7K |
44 |
10/08/24 |
10/08/24 |
ASX - By Stock
|
13
|
6.7K
|
44
|
|